A U.S. Food and Drug Administration perspective on cannabis research and drug development

Since the early 1970s, the U.S. Food and Drug Administration (FDA) has received over 800 investigational new drug applications (INDs) for, and pre-INDs pertaining to, research of cannabis or cannabis-derived products. The current data show that applications for research of these products submitted b...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Cassandra L. Taylor (Autore), Schuyler A. Pruyn (Autore)
Natura: Libro
Pubblicazione: Open Exploration Publishing Inc., 2023-10-01T00:00:00Z.
Soggetti:
Accesso online:Connect to this object online.
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne!!